Filter Results
:
(14,050)
Show Results For
-
All HBS Web
(14,050)
- People (46)
- News (3,795)
- Research (7,504)
- Events (64)
- Multimedia (285)
- Faculty Publications (5,412)
Show Results For
-
All HBS Web
(14,050)
- People (46)
- News (3,795)
- Research (7,504)
- Events (64)
- Multimedia (285)
- Faculty Publications (5,412)
- spring 1996
- Article
Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery." RAND Journal of Economics 27, no. 1 (spring 1996): 32–59.
- May 2009
- Teaching Note
The World Food Programme during the Global Food Crisis (TN) (A) and (B)
By: Eric D. Werker
Teaching Note for [709024] and [709052].
View Details
- Article
Front-line Staff Perspectives on Opportunities for Improving the Safety and Efficiency of Hospital Work Systems
By: Anita L. Tucker, Sara J. Singer, Jennifer E. Hayes and Alyson Falwell
Objective To link safety-related concerns raised by frontline staff about hospital work systems (operational failures) to the safety and efficiency of hospitals, and to contrast these concerns with national patient safety initiatives.
Data... View Details
Keywords:
Perspective;
Opportunities;
Safety;
Performance Efficiency;
System;
Failure;
Conferences;
Employees;
Management Analysis, Tools, and Techniques;
Experience and Expertise;
Health Care and Treatment;
Health Industry;
United States
Tucker, Anita L., Sara J. Singer, Jennifer E. Hayes, and Alyson Falwell. "Front-line Staff Perspectives on Opportunities for Improving the Safety and Efficiency of Hospital Work Systems." Health Services Research 43, nos. 5, pt.2 (October 2008).
- 1991
- Book
Facilitating Foreign Investment: Government Institutions to Screen and Monitor Investment from Abroad
By: L. T. Wells Jr. and A. G. Wint
Wells, L. T., Jr., and A. G. Wint. Facilitating Foreign Investment: Government Institutions to Screen and Monitor Investment from Abroad. Foreign Investment Advisory Service Occasional Paper. Washington, D.C.: International Finance Corporation, 1991.
- April 2011 (Revised March 2012)
- Supplement
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
By: Arthur A. Daemmrich
Supplement to "U.S. Healthcare Reform: International Perspectives" updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Government Legislation;
Political Elections;
Health Care and Treatment;
Lawsuits and Litigation;
Business and Government Relations;
Public Opinion;
Health Industry;
Health Industry;
United States
Daemmrich, Arthur A. "U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010." Harvard Business School Supplement 711-103, April 2011. (Revised March 2012.)
- January 2021 (Revised March 2021)
- Exercise
E-Commerce Analytics for CPG Firms (A): Estimating Sales
By: Ayelet Israeli and Fedor (Ted) Lisitsyn
The E-Commerce Analytics group at the traditional CPG firm was in charge of compiling various online sales reports, as well as making data-driven recommendations for sales and marketing tactics. In a series of exercises, students address different data challenges for...
View Details
Keywords:
Data Analysis;
Data Analytics;
CPG;
Consumer Packaged Goods (CPG);
Estimation;
Online Channel;
Retail Analytics;
Retail;
Retailing Industry;
Data;
Data Sharing;
Bricks And Mortar;
Ecommerce;
Direct-to-consumer;
DTC;
Analytics and Data Science;
Sales;
Marketing;
E-commerce;
Retail Industry;
Consumer Products Industry;
United States
Israeli, Ayelet, and Fedor (Ted) Lisitsyn. "E-Commerce Analytics for CPG Firms (A): Estimating Sales." Harvard Business School Exercise 521-078, January 2021. (Revised March 2021.)
- May 2021 (Revised August 2021)
- Case
Melissa Wood Health: How to Win in the Creator Economy
By: Eva Ascarza
In October 2020, Melissa Wood-Tepperberg, founder of the digital subscription wellness platform Melissa Wood Health (MWH) and creator of ‘The MWH Method,’ was evaluating the strategic directions of her company. What had started as a way to share workouts and wellness...
View Details
Ascarza, Eva. "Melissa Wood Health: How to Win in the Creator Economy." Harvard Business School Case 521-086, May 2021. (Revised August 2021.)
- January 2020
- Teaching Note
GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (A) and (B)
This teaching note is meant to accompany “GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (A),” HBS No. 820-041, and “GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (B),” HBS No. 820-074. The cases follow Nitin Thakor, President...
View Details
- 6 PM – 7:15 PM EST, 28 Feb 2022
- Virtual Programming
A Blessing and Little Black Library at Harvard Business School presents a virtual author chat to celebrate Black History Month
HBSs iconic Baker Library is the largest business library in the worldand its collection expanded during the COVID-19 pandemic. For the first time in its 95-year history, Baker brought in non-business books, over 170 titles (to date) organized by Cathy Chukwulebe (MBA...
View Details
- 2020
- Working Paper
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
By: Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver
COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order...
View Details
Keywords:
COVID-19;
Convalescent Plasma;
Vouchers;
Health Pandemics;
Health Care and Treatment;
Resource Allocation;
Market Design
Kominers, Scott Duke, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver. "Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design." Harvard Business School Working Paper, No. 20-116, May 2020. (NBER Working Paper Series, No. 27143, May 2020.)
- 2006
- Chapter
BioRisk: interleukin-2 from laboratory to market in the United States and Germany
By: Arthur A. Daemmrich
- April 12, 2022
- Article
Evaluation of Individual and Ensemble Probabilistic Forecasts of COVID-19 Mortality in the United States
By: Estee Y. Cramer, Evan L. Ray, Velma K. Lopez, Johannes Bracher, Andrea Brennen, Alvaro J. Castro Rivadeneira, Michael Lingzhi Li and et al.
Short-term probabilistic forecasts of the trajectory of the COVID-19 pandemic in the United States have served as a visible and important communication channel between the scientific modeling community and both the general public and decision-makers. Forecasting models...
View Details
Keywords:
COVID-19;
Forecasting and Prediction;
Health Pandemics;
Mathematical Methods;
Partners and Partnerships
Cramer, Estee Y., Evan L. Ray, Velma K. Lopez, Johannes Bracher, Andrea Brennen, Alvaro J. Castro Rivadeneira, Michael Lingzhi Li, and et al. "Evaluation of Individual and Ensemble Probabilistic Forecasts of COVID-19 Mortality in the United States." e2113561119. Proceedings of the National Academy of Sciences 119, no. 15 (April 12, 2022). (See full author list here.)
- 19 May 2016
- Research Event
Crowdsourcing, Patent Trolls, and Other Research Insights Highlighted at Harvard Business School Symposium
for alleged patent violations, and it seems they do so regardless of whether patents were infringed on or not. NPEs are well aware that with intellectual property, the idea space is nebulous—which can lead...
View Details
Keywords:
by Dina Gerdeman & Carmen Nobel
- Web
The Institute for Cancer Care Innovation - Institute For Strategy And Competitiveness
Michael Porter and his work to promote value-based health care delivery in the U.S. health care system. By leveraging the experience of both internal View Details
- fall 2002
- Article
Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
- 01 Jun 1997
- News
Competition and Strategy Unit at HBS Sets Pace In Its Field
practice." Indeed, C&S faculty have recently published a number of books that have been well received in the academic and business press. Professor Adam M. Brandenburger's Co-opetition, for instance, is a...
View Details
Keywords:
Susan Young
- 07 Jul 2015
- Blog Post
From Teach for America – to HBS – and Back Again
that HBS was a residential school. I spoke to students at business schools in NYC and they griped about not having the opportunity to get to know their classmates well because everyone seemed to have other...
View Details